- Report
- April 2023
- 240 Pages
Global
From €2498EUR$2,800USD£2,203GBP
€3123EUR$3,500USD£2,754GBP
- Report
- February 2024
- 110 Pages
Global
From €4238EUR$4,750USD£3,737GBP
- Report
- April 2023
- 115 Pages
Global
From €4238EUR$4,750USD£3,737GBP
- Report
- May 2024
- 182 Pages
Global
From €4015EUR$4,500USD£3,540GBP
- Report
- October 2024
- 140 Pages
Global
From €2231EUR$2,500USD£1,967GBP
- Report
- April 2023
- 160 Pages
Global
From €4416EUR$4,949USD£3,894GBP
- Report
- April 2023
- 116 Pages
Global
From €4015EUR$4,500USD£3,540GBP
- Report
- October 2022
- 81 Pages
Global
From €3119EUR$3,495USD£2,750GBP
- Report
- August 2024
- 101 Pages
China
From €1606EUR$1,800USD£1,416GBP
- Report
- August 2024
- 133 Pages
China
From €1606EUR$1,800USD£1,416GBP
- Report
- January 2024
- 109 Pages
United States
€3123EUR$3,500USD£2,754GBP
- Report
- February 2018
- 680 Pages
Global
From €19630EUR$22,000USD£17,309GBP
- Report
- October 2024
- 90 Pages
Global
From €3500EUR$4,202USD£3,194GBP
- Report
- October 2023
- 101 Pages
Global
From €3500EUR$4,202USD£3,194GBP
- Report
- August 2023
- 94 Pages
Global
From €3500EUR$4,202USD£3,194GBP
- Report
- May 2023
- 94 Pages
Global
From €3500EUR$4,202USD£3,194GBP
- Report
- March 2022
- 101 Pages
Global
From €3500EUR$4,202USD£3,194GBP
- Report
- March 2022
- 105 Pages
Global
From €3500EUR$4,202USD£3,194GBP
- Report
- January 2025
- 132 Pages
Global
From €848EUR$950USD£747GBP
- Report
- January 2025
- 132 Pages
Global
From €848EUR$950USD£747GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more